Turkish Republic, Ministry of Health to acquire advanced cancer treatment systems from Gatwick Diamond-based Elekta
26 February 2015
Seven hospitals to acquire linear accelerators and sophisticated software for radiation therapy
Elekta (EKTA-B.ST) has received an order from the Republic of Turkey’s Ministry of Health (Directorate General of Health for Border and Coastal Areas) for nine Elekta Synergy® linear accelerators (linacs), all including Agility™ multileaf collimators for high-resolution beam shaping, as well as Monaco® 5.0 treatment planning system and MOSAIQ® oncology information system.
Elekta Synergy allows physicians to better visualize tumors while Agility enables precise shaping of the radiation beam around the tumor. Using volumetric modulated arc therapy (VMAT) technology facilitates rapid treatment time, benefitting both the hospitals and patients.
According to the World Health Organization, almost 258 per 100,000 people in Turkey are diagnosed with cancer each year. Cancer is the second leading cause of death in Turkey and the most common cancers for men and women are lung and breast, respectively. Elekta Synergy has been clinically proven to be effective in managing both types of cancer, as well as several other indications. 
Ian Alexander, Executive Vice President of Elekta's Region Europe, Africa, Latin America and Middle East, says: “We are delighted to provide the treatment solutions that will allow the Turkish Ministry of Health to offer state-of-the-art cancer care. We’re especially pleased that many of the hospitals are new customers to Elekta.
“This is the first major deal procured by our new entity, Elekta Turkey, which was developed through the recent acquisition of Mesi Medikal. We look forward to increased collaboration between our unit and the country’s health care sector.”
Elekta was awarded the contract based on a public tender where price and performance were the key criteria. The total value of the deal is almost EUR 16 million (approximately USD 18.5 million) and has been booked during Elekta’s third quarter 2014/15.
 The International Agency for Research on Cancer (IARC), GLOBOCAN project
 Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates
Published online Nov 11, 2014. doi: 10.1186/s13014-014-0243-1
 Single-Arc Volumetric Modulated Arc Therapy Planning for Left Breast Cancer and Regional Nodes
Journal of Radiation Research, Jan 2012